KOE · 117730.KQ
T-Robotics.Co.,Ltd.
₩11,970-₩720 (-5.67%)
T-Robotics.Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 61.26% below the high.
Loading market information…
KOE · 253840.KQ · KRW
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
Sugentech Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.79% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Sugentech Inc.’s forward annual dividend is ₩150 per share, paid annual. The forward yield is 3.69% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Sugentech Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Sugentech Inc., a South Korean firm, develops and markets advanced in-vitro diagnostic (IVD) systems and products worldwide. Their solutions integrate biotechnology, information technology, and nanotechnology. The company's diverse portfolio features sophisticated Multiplex BLOT disease diagnostic platforms, including automated immunoblot processors and molecular diagnostic tools, alongside various test kits. They also offer a range of convenient self-testing products, such as digital ovulation, pregnancy, and early pregnancy detection kits, as well as mobile testing options. Additionally, Sugentech provides point-of-care (POC) analyzers and tests for a broad spectrum of conditions, from infectious diseases like M.tuberculosis, M.bovis, SARS-CoV-2 (antibodies and antigens), and influenza A/B, to critical biomarkers such as CRP/hsCRP/dualCRP, procalcitonin, troponin I, hemoglobinA1c, and human chorionic gonadotropin. Founded in 2011, the company, originally named Accugen Healthcare, Inc., adopted its current name, Sugentech Inc., in October 2013 and is headquartered in Daejeon.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:28 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩11,970-₩720 (-5.67%)
T-Robotics.Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 61.26% below the high.
₩6,570-₩110 (-1.65%)
Hyundai Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 58.83% below the high.
₩990-₩27 (-2.65%)
Enzychem Lifesciences Corporation’s quoted price sits in the lower half of its reported 52-week range, 43.94% below the high.
₩3,345-₩55 (-1.62%)
KUKJE PHARMA Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 38.85% below the high.
₩4,245-₩50 (-1.16%)
Ray Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 63.69% below the high.
₩5,660-₩70 (-1.22%)
Ildong Holdings Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 67.04% below the high.
₩1,882+₩21 (+1.13%)
Cellid, Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 60.46% below the high.
₩2,875-₩155 (-5.12%)
Oncocross Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 80.16% below the high.
